The human tumor microbiome is composed of tumor type-specific intracellular bacteria.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 29 07 2019
revised: 22 01 2020
accepted: 14 04 2020
entrez: 30 5 2020
pubmed: 30 5 2020
medline: 13 6 2020
Statut: ppublish

Résumé

Bacteria were first detected in human tumors more than 100 years ago, but the characterization of the tumor microbiome has remained challenging because of its low biomass. We undertook a comprehensive analysis of the tumor microbiome, studying 1526 tumors and their adjacent normal tissues across seven cancer types, including breast, lung, ovary, pancreas, melanoma, bone, and brain tumors. We found that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome. The intratumor bacteria are mostly intracellular and are present in both cancer and immune cells. We also noted correlations between intratumor bacteria or their predicted functions with tumor types and subtypes, patients' smoking status, and the response to immunotherapy.

Identifiants

pubmed: 32467386
pii: 368/6494/973
doi: 10.1126/science.aay9189
pmc: PMC7757858
mid: NIHMS1645237
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

973-980

Subventions

Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009599
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Gastroenterology. 2017 Dec;153(6):1621-1633.e6
pubmed: 28823860
Genome Med. 2016 Jul 01;8(1):72
pubmed: 27363992
Nat Med. 2019 Mar;25(3):377-388
pubmed: 30842679
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Microbiome. 2016 Jun 23;4(1):29
pubmed: 27338728
ACS Chem Biol. 2013 Mar 15;8(3):500-5
pubmed: 23240806
Trends Microbiol. 2019 Feb;27(2):105-117
pubmed: 30497919
BJOG. 2020 Jan;127(2):159-169
pubmed: 31376240
J Cardiothorac Surg. 2011 Oct 14;6:137
pubmed: 21999143
Bioinformatics. 2018 Mar 15;34(6):1053-1055
pubmed: 29091997
Prostate. 2008 Feb 15;68(3):306-20
pubmed: 18163428
Bioeng Bugs. 2010 Nov-Dec;1(6):385-94
pubmed: 21468205
Biochem Soc Trans. 2017 Apr 15;45(2):287-295
pubmed: 28408469
Rev Environ Health. 2017 Sep 26;32(3):267-277
pubmed: 28284039
Cancer Discov. 2018 Apr;8(4):403-416
pubmed: 29567829
PLoS One. 2012;7(4):e35957
pubmed: 22558281
Microbiome. 2018 Jan 26;6(1):17
pubmed: 29373999
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
J Microbiol Methods. 2006 Jul;66(1):21-31
pubmed: 16305811
PLoS One. 2014 Jan 08;9(1):e83744
pubmed: 24421902
Inflamm Bowel Dis. 2012 Apr;18(4):649-56
pubmed: 21826768
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12749-12754
pubmed: 29138318
J Microsc. 1986 Aug;143(Pt 2):139-49
pubmed: 3531524
J Gen Microbiol. 1949 Sep;3(3):434-43
pubmed: 18147756
Bioinformatics. 2015 May 15;31(10):1674-6
pubmed: 25609793
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
Transl Res. 2017 Jan;179:139-154
pubmed: 27554797
Genome Res. 2012 Feb;22(2):299-306
pubmed: 22009989
Front Microbiol. 2018 May 15;9:951
pubmed: 29867857
Appl Environ Microbiol. 1990 Jun;56(6):1919-25
pubmed: 2200342
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):731-740
pubmed: 30733306
Nature. 2019 Aug;572(7769):329-334
pubmed: 31367035
Oncotarget. 2017 May 30;8(22):36225-36245
pubmed: 28410234
Appl Environ Microbiol. 2016 Jul 29;82(16):5039-48
pubmed: 27342554
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
BMC Cancer. 2011 Jun 21;11:262
pubmed: 21693047
Am J Gastroenterol. 2009 Dec;104(12):3058-67
pubmed: 19755974
Open Biol. 2013 Jan 08;3(1):120143
pubmed: 23303308
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12115-20
pubmed: 16880384
Sci Rep. 2018 Nov 15;8(1):16893
pubmed: 30442969
PeerJ. 2015 Jun 18;3:e1029
pubmed: 26157614
Front Microbiol. 2015 Feb 02;6:20
pubmed: 25699023
Infect Agent Cancer. 2013 Mar 28;8(1):11
pubmed: 23537317
J Pathol. 2018 Apr;244(5):667-676
pubmed: 29377130
J Immunol. 1999 Jun 1;162(11):6784-91
pubmed: 10352299
Gut Pathog. 2016 May 26;8:24
pubmed: 27239228
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
PLoS One. 2017 Nov 30;12(11):e0188873
pubmed: 29190829
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
Antioxid Redox Signal. 2018 Feb 20;28(6):487-504
pubmed: 28372502
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Annu Rev Biochem. 2002;71:635-700
pubmed: 12045108
Nat Methods. 2012 Dec;9(12):1185-8
pubmed: 23103880
Nature. 2020 Mar;579(7800):567-574
pubmed: 32214244
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
Genome Biol. 2018 Aug 24;19(1):123
pubmed: 30143034
Cell Host Microbe. 2013 Aug 14;14(2):207-15
pubmed: 23954159
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Anal Quant Cytol Histol. 2001 Aug;23(4):291-9
pubmed: 11531144
Genome Biol. 2016 Jul 28;17(1):163
pubmed: 27468850
Microbiome. 2018 Mar 2;6(1):45
pubmed: 29499759
Nagoya J Med Sci. 1967 Mar;29(4):345-67
pubmed: 6066099
Appl Environ Microbiol. 2014 May;80(10):3007-14
pubmed: 24610844
PLoS Comput Biol. 2009 Aug;5(8):e1000465
pubmed: 19680427
Science. 2017 Sep 15;357(6356):1156-1160
pubmed: 28912244
Cancer Cell. 2015 Jan 12;27(1):27-40
pubmed: 25533336
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Mol Ecol Resour. 2019 Jul;19(4):982-996
pubmed: 30887686

Auteurs

Deborah Nejman (D)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Ilana Livyatan (I)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Garold Fuks (G)

Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.

Nancy Gavert (N)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Yaara Zwang (Y)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Leore T Geller (LT)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Aviva Rotter-Maskowitz (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Roi Weiser (R)

Division of Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Giuseppe Mallel (G)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Elinor Gigi (E)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Arnon Meltser (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Gavin M Douglas (GM)

Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.

Iris Kamer (I)

Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Vancheswaran Gopalakrishnan (V)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Tali Dadosh (T)

Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.

Smadar Levin-Zaidman (S)

Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.

Sofia Avnet (S)

Orthopaedic Pathophysiology and Regenerative Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Tehila Atlan (T)

Department of Bioinformatics, Jerusalem College of Technology, Jerusalem, Israel.

Zachary A Cooper (ZA)

Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.

Reetakshi Arora (R)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Alexandria P Cogdill (AP)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Md Abdul Wadud Khan (MAW)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gabriel Ologun (G)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yuval Bussi (Y)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Adina Weinberger (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Maya Lotan-Pompan (M)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Ofra Golani (O)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Gili Perry (G)

Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.

Merav Rokah (M)

Department of Thoracic Surgery, Sheba Medical Center, Ramat Gan, Israel.

Keren Bahar-Shany (K)

Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.

Elisa A Rozeman (EA)

Department of Medical Oncology and Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.

Christian U Blank (CU)

Department of Medical Oncology and Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.

Anat Ronai (A)

Pediatric Gastroenterology Institute, Rambam Medical Center, Haifa, Israel.

Ron Shaoul (R)

Pediatric Gastroenterology Institute, Rambam Medical Center, Haifa, Israel.

Amnon Amit (A)

Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Obstetrics and Gynecology, Rambam Health Care Campus, Haifa, Israel.

Tatiana Dorfman (T)

Division of General Surgery, Rambam Health Care Campus, Haifa, Israel.
Ambulatory and Breast Surgery Service, Rambam Health Care Campus, Haifa, Israel.

Ran Kremer (R)

Department of Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel.

Zvi R Cohen (ZR)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Neurosurgery, Sheba Medical Center, Ramat Gan, Israel.

Sagi Harnof (S)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Neurosurgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.

Tali Siegal (T)

Neuro-Oncology Unit, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.

Einav Yehuda-Shnaidman (E)

Institute of Pathology, Megalab, Maccabi Healthcare Services, Rehovot, Israel.

Einav Nili Gal-Yam (EN)

Breast Oncology Institute, Sheba Medical Center, Ramat Gan, Israel.

Hagit Shapira (H)

Institute of Pathology, Megalab, Maccabi Healthcare Services, Rehovot, Israel.

Nicola Baldini (N)

Orthopaedic Pathophysiology and Regenerative Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Morgan G I Langille (MGI)

Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.
Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.

Alon Ben-Nun (A)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Thoracic Surgery, Sheba Medical Center, Ramat Gan, Israel.

Bella Kaufman (B)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Aviram Nissan (A)

Department of Surgical Oncology (Surgery C), Sheba Medical Center, Ramat Gan, Israel.

Talia Golan (T)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Maya Dadiani (M)

Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.

Keren Levanon (K)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.

Jair Bar (J)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Shlomit Yust-Katz (S)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Neuro-Oncology Unit, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.

Iris Barshack (I)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Pathology, Sheba Medical Center, Ramat Gan, Israel.

Daniel S Peeper (DS)

Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.

Dan J Raz (DJ)

Division of Thoracic Surgery, City of Hope Medical Center, Duarte, CA, USA.

Eran Segal (E)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Jennifer A Wargo (JA)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Judith Sandbank (J)

Institute of Pathology, Megalab, Maccabi Healthcare Services, Rehovot, Israel.

Noam Shental (N)

Department of Mathematics and Computer Science, The Open University of Israel, Ra'anana, Israel.

Ravid Straussman (R)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ravidst@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH